These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18446109)

  • 1. Tadalafil improves oxygenation in a model of newborn pulmonary hypertension.
    Tessler RB; Zadinello M; Fiori H; Colvero M; Belik J; Fiori RM
    Pediatr Crit Care Med; 2008 May; 9(3):330-2. PubMed ID: 18446109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratracheal administration of sildenafil and surfactant alleviates the pulmonary hypertension in newborn piglets.
    Obaid L; Johnson ST; Bigam DL; Cheung PY
    Resuscitation; 2006 May; 69(2):287-94. PubMed ID: 16500016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model.
    Weiss ES; Champion HC; Williams JA; Baumgartner WA; Shah AS
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1249-57. PubMed ID: 19379999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral tadalafil in pulmonary artery hypertension: a prospective study.
    Aggarwal P; Patial RK; Negi PC; Marwaha R
    Indian Heart J; 2007; 59(4):329-35. PubMed ID: 19126938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension.
    Affuso F; Palmieri EA; Di Conza P; Guardasole V; Fazio S
    Int J Cardiol; 2006 Apr; 108(3):429-31. PubMed ID: 16260051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the phosphodiesterase type 5 inhibitor tadalafil on pulmonary hemodynamics in a canine model of pulmonary hypertension.
    Hori Y; Kondo C; Matsui M; Yamagishi M; Okano S; Chikazawa S; Kanai K; Hoshi F; Itoh N
    Vet J; 2014 Nov; 202(2):334-9. PubMed ID: 25178687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of PDE-5 inhibitor tadalafil in pulmonary arterial hypertension.
    Bharani A; Patel A; Saraf J; Jain A; Mehrotra S; Lunia B
    Indian Heart J; 2007; 59(4):323-8. PubMed ID: 19126937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low-volume hemoglobin glutamer-200 versus normal saline and arginine vasopressin resuscitation on systemic and skeletal muscle blood flow and oxygenation in a canine hemorrhagic shock model.
    Driessen B; Zarucco L; Gunther RA; Burns PM; Lamb SV; Vincent SE; Boston RA; Jahr JS; Cheung AT
    Crit Care Med; 2007 Sep; 35(9):2101-9. PubMed ID: 17581486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema.
    Fischler M; Maggiorini M; Dorschner L; Debrunner J; Bernheim A; Kiencke S; Mairbäurl H; Bloch KE; Naeije R; Brunner-La Rocca HP
    Am J Respir Crit Care Med; 2009 Aug; 180(4):346-52. PubMed ID: 19520908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
    Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
    Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
    Noori S; Friedlich P; Wong P; Garingo A; Seri I
    Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study.
    Mukhopadhyay S; Sharma M; Ramakrishnan S; Yusuf J; Gupta MD; Bhamri N; Trehan V; Tyagi S
    Circulation; 2006 Oct; 114(17):1807-10. PubMed ID: 17030688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension.
    Arif SA; Poon H
    Clin Ther; 2011 Aug; 33(8):993-1004. PubMed ID: 21762988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension.
    Pepke-Zaba J; Beardsworth A; Chan M; Angalakuditi M
    Curr Med Res Opin; 2009 Oct; 25(10):2479-85. PubMed ID: 19686085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central hemodynamic and regional blood flow changes in the newborn with right ventricular hypertension.
    Belik J; Baron K; Light RB
    Pediatr Res; 1989 Dec; 26(6):548-53. PubMed ID: 2602032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets.
    Binns-Loveman KM; Kaplowitz MR; Fike CD
    Pediatr Pulmonol; 2005 Jul; 40(1):72-80. PubMed ID: 15880376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous vasoactive intestinal polypeptide lowers pulmonary-to-systemic vascular resistance ratio in a neonatal piglet model of pulmonary arterial hypertension.
    Haydar S; Sarti JF; Grisoni ER
    J Pediatr Surg; 2007 May; 42(5):758-64. PubMed ID: 17502178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tadalafil, a long-acting inhibitor of PDE5, improves pulmonary hemodynamics and survival rate of monocrotaline-induced pulmonary artery hypertension in rats.
    Sawamura F; Kato M; Fujita K; Nakazawa T; Beardsworth A
    J Pharmacol Sci; 2009 Nov; 111(3):235-43. PubMed ID: 19881228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog.
    Serres F; Nicolle AP; Tissier R; Gouni V; Pouchelon JL; Chetboul V
    J Vet Med A Physiol Pathol Clin Med; 2006 Apr; 53(3):129-33. PubMed ID: 16533328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.